Health · Full coverage
Vitiligo Is More Than a Cosmetic Issue, Doctors Say on World Awareness Day
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
50% center
Center 1Right 1
First reported by Arutz Sheva · Jun 24, 2026
What happened
On World Vitiligo Awareness Day, doctors emphasized that vitiligo is an autoimmune disease, not just a cosmetic issue. The article reviews its prevalence, psychological impact, and newer treatments, including FDA-approved JAK therapy and ongoing trials of oral drugs. It says care should be tailored to the extent, location, and activity of the disease.
- 01Vitiligo affects about 0.5% to 2% of people worldwide, and roughly 45,000 Israelis.
- 02More than 40% of patients say it affects daily decisions, social life, and intimacy.
- 03Doctors say a small facial patch can be more severe than a larger hidden one.
- 04Current treatments include creams, phototherapy, and newer JAK-targeted therapies.
- 05World Vitiligo Awareness Day is observed on June 25.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Teva Reports Positive Phase 1b Results for Vitiligo Antibody, Plans Phase 2b in 2026Jul 7, 2026Model Coral Simanovich Reveals Her Psoriasis Battle, Highlighting Chronic Skin Disease ChallengesAug 17, 2026Israeli Panel Highlights Challenges of Invisible Diseases Affecting Thousands of WomenJul 12, 2026Dermatologists Warn Against Removing Moles Without Medical Evaluation to Avoid Delayed Skin Cancer DiagnosisJul 28, 2026Hadassah Dermatology Chief Warns Against Unsupervised Mole Removal Due to Melanoma RisksJun 28, 2026Doctors’ Day: When Medical Responsibility Meets the Human Side of CareJan 11, 2026
